HTA288 How Have Surrogate Outcomes Been Dealt With in Existing HTA Evaluations by Different HTA Bodies and What Lessons Can Be Learnt? von Flight, L, Salih, F, Garrett, Z, Collins, S, Aung, P.T., Coory, M, Ollendorf, D, Richardson, M, Dawoud, D

Volltext

P27 Considerations for Model Conceptualisation When Using Surrogate Outcomes to Inform HTA Decision-Making von Salih, F, Flight, L, Garrett, Z, Collins, S, Guo, Y, Mccracken, F, Knies, S, Efe, R, Lee, K, Husein, F, Hogan, ME, Morenz, E, Kaunelis, D, Gates, M, Bryan, M, Ollendorf, D, Tunis, S, Richardson, M, Coory, M, Aung, P.T., Robayo, A, Dawoud, D

Volltext

Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer von Lai, Gillianne G Y, Lim, Tse Hui, Lim, John, Liew, Perry J R, Kwang, Xue Lin, Nahar, Rahul, Aung, Zaw Win, Takano, Angela, Lee, Yin Yeng, Lau, Dawn P X, Tan, Gek San, Tan, Sze Huey, Tan, Wan Ling, Ang, Mei-Kim, Toh, Chee Keong, Tan, Bien Soo, Devanand, Anantham, Too, Chow Wei, Gogna, Apoorva, Ong, Boon Hean, Koh, Tina P T, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Yuan, Ju, Lim, Tony Kiat Hon, Lim, Alvin S T, Hillmer, Axel M, Lim, Wan Teck, Iyer, N Gopalakrishna, Tam, Wai Leong, Zhai, Weiwei, Tan, Eng-Huat, Tan, Daniel S W

Volltext

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiven... von Tan, Aaron C., Lai, Gillianne G.Y., Tan, Gek San, Poon, Shou Yu, Doble, Brett, Lim, Tse Hui, Aung, Zaw Win, Takano, Angela, Tan, Wan Ling, Ang, Mei-Kim, Tan, Bien Soo, Devanand, Anantham, Too, Chow Wei, Gogna, Apoorva, Ong, Boon-Hean, Koh, Tina P.T., Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Lim, Alvin S.T., Lim, Wan Teck, Toh, Chee Keong, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel S.W.

Volltext

Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing von Nahar, Rahul, Zhai, Weiwei, Zhang, Tong, Takano, Angela, Khng, Alexis J., Lee, Yin Yeng, Liu, Xingliang, Lim, Chong Hee, Koh, Tina P. T., Aung, Zaw Win, Lim, Tony Kiat Hon, Veeravalli, Lavanya, Yuan, Ju, Teo, Audrey S. M., Chan, Cheryl X., Poh, Huay Mei, Chua, Ivan M. L., Liew, Audrey Ann, Lau, Dawn Ping Xi, Kwang, Xue Lin, Toh, Chee Keong, Lim, Wan-Teck, Lim, Bing, Tam, Wai Leong, Tan, Eng-Huat, Hillmer, Axel M., Tan, Daniel S. W.

Volltext

Clinical outcome of treatment without trastuzumab in HER2 positive breast cancer patients von Aye, T.T., Mon, S., Khine, M., Sein, N., Thant, N.M., Win, A.K., Aung, E.P.P., Hnin, P.T.

Volltext

Myanmar clinicians' preference of truth telling about cancer diagnosis von Mon, S., Aye, T.T., Khine, M., Htay, S.S., Sein, N., Aung, E.P.P., Hnin, P.T., Thaung, S.L.L.

Volltext

79P Molecular targeted therapy for Her2 positive breast cancer in private sector: Yangon experience von Khine, M., Mon, S., Sein, N., Aye, T.T., Htay, S.S., Kyaw, N.H., Aung, E.P.P., Hnin, P.T.

Volltext

79P Molecular targeted therapy for Her2 positive breast cancer in private sector: Yangon experience von Khine, M., Mon, S., Sein, N., Aye, T.T., Htay, S.S., Kyaw, N.H., Aung, E.P.P., Hnin, P.T.

Volltext

86P Overview of breast cancer management: Yangon private sector cancer care von Mon, S., Aye, T.T., Khine, M., Aung, E.P.P., Nyunt, A.S., Hnin, P.T., Htay, S.S., Sein, N., Khaing, E.

Volltext

86P Overview of breast cancer management: Yangon private sector cancer care von Mon, S., Aye, T.T., Khine, M., Aung, E.P.P., Nyunt, A.S., Hnin, P.T., Htay, S.S., Sein, N., Khaing, E.

Volltext

Defining “occludable” angles in population surveys: drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people von Foster, P J, Aung, T, Nolan, W P, Machin, D, Baasanhu, J, Khaw, P T, Alsbirk, P-H, Lee, P S, Seah, S K L, Johnson, G J

Volltext

Comparing genomic landscape of early stage, treatment naïve and late stage, drug resistant EGFR-mutant lung adenocarcinomas von Nahar, Rahul, Lee, Yin Yeng, Khng, Alexis J., Zhang, Tong, Takano, Angela, Liu, Xingliang, Alvarez, Jacob J.S., Zelichov, Ori, Ella, Ezra, Barbash, Zohar, Lim, Chong Hee, Koh, Tina P.T., Aung, Zaw Win, Lim, Tony Kiat Hon, Toh, Chee Keong, Lim, Wan-Teck, Lim, Bing, Tam, Wai Leong, Tan, Eng-Huat, Zhai, Weiwei, Tan, Daniel S.W., Hillmer, Axel M.

Volltext